標普:Tesla(TSLA.US)在美國新車市佔率降至65% 料2025年跌至不足20%
標普(S&P Global Mobility)數據顯示,Tesla(TSLA.US)仍然是美國最暢銷電動車品牌,但主導地位正在削弱。截至第三季,Tesla佔美國新車註冊量的佔比爲65%,低於去年的71%及2020年的79%,預計到2025年將降至不足20%,而屆時整體電動車車型的數量預計將從目前的48款增加至159款。
報告提到,Tesla正在逐步失去在美國電動車市場的控制權,取而代之的是價格低於5萬美元的全電動車型,而Tesla尚未在這個市場展開真正的競爭,隨著更新及更實惠的選擇出現,Tesla的主導地位將會受到挑戰。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.